← Back to Search

Prosthetic Device

Pointdexter for Amputation

N/A
Waitlist Available
Research Sponsored by Liberating Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of study: (in-lab: ~4 hours, take-home: ~4 weeks).
Awards & highlights

Study Summary

This study is evaluating whether a prosthetic fingertip can be used to control a prosthetic hand.

Eligible Conditions
  • Amputation
  • Hand Amputation
  • Congenital Upper Limb Absence
  • Prosthesis User

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of study: (in-lab: ~4 hours, take-home: ~4 weeks).
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of study: (in-lab: ~4 hours, take-home: ~4 weeks). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Jebsen-Taylor Small Common Objects Functional Test
User and Clinician Feedback
Secondary outcome measures
Patient-Specific Functional Scale (PSFS) Survey

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PointdexterExperimental Treatment1 Intervention
The subject wears a modified version of their usual partial hand prosthesis. The modification replaces the usual index finger of the partial hand prosthesis with the investigational Pointdexter device. Subjects will either test out this hand configuration in the lab while performing functional outcome measures or at home in their daily lives for approximately four weeks.
Group II: Comparator BaselineActive Control1 Intervention
The subject wears their usual partial hand prosthesis while performing functional outcome measures.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pointdexter
2021
N/A
~10

Find a Location

Who is running the clinical trial?

Össur EhfIndustry Sponsor
20 Previous Clinical Trials
3,863 Total Patients Enrolled
Liberating Technologies, Inc.Lead Sponsor
11 Previous Clinical Trials
93 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Dexterous Partial Hand Prosthesis Outcomes
Todd Farrell 2021. "Dexterous Partial Hand Prosthesis Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05038566.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top